Cargando…

Treatment-resistant depression and peripheral C-reactive protein

BACKGROUND: C-reactive protein (CRP) is a candidate biomarker for major depressive disorder (MDD), but it is unclear how peripheral CRP levels relate to the heterogeneous clinical phenotypes of the disorder. AIM: To explore CRP in MDD and its phenotypic associations. METHOD: We recruited 102 treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamberlain, Samuel R., Cavanagh, Jonathan, de Boer, Peter, Mondelli, Valeria, Jones, Declan N.C., Drevets, Wayne C., Cowen, Philip J., Harrison, Neil A., Pointon, Linda, Pariante, Carmine M., Bullmore, Edward T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124647/ https://www.ncbi.nlm.nih.gov/pubmed/29764522 http://dx.doi.org/10.1192/bjp.2018.66

Ejemplares similares

No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing
por: Cole, John J., et al.
Publicado: (2021)

The influence of comorbid depression and overweight status on peripheral inflammation and cortisol levels
por: McLaughlin, Anna P., et al.
Publicado: (2022)

Childhood trauma, HPA axis activity and antidepressant response in patients with depression
por: Nikkheslat, Naghmeh, et al.
Publicado: (2020)

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study
por: Sforzini, Luca, et al.
Publicado: (2023)

Peripheral inflammation is associated with micro-structural and functional connectivity changes in depression-related brain networks
por: Kitzbichler, Manfred G., et al.
Publicado: (2021)

Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
por: Cattaneo, Annamaria, et al.
Publicado: (2020)

Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
por: Cattaneo, Annamaria, et al.
Publicado: (2020)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

Genetic Contributions of Inflammation to Depression
por: Barnes, Jacob, et al.
Publicado: (2017)

Choroid plexus enlargement is associated with neuroinflammation and reduction of blood brain barrier permeability in depression
por: Althubaity, Noha, et al.
Publicado: (2021)

A Modest Increase in (11)C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index
por: Schubert, Julia J., et al.
Publicado: (2021)

Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
por: Kopra, Emma, et al.
Publicado: (2021)

What can neuroimmunology teach us about the symptoms of long-COVID?
por: Mondelli, Valeria, et al.
Publicado: (2021)

Inflammation in cancer and depression: a starring role for the kynurenine pathway
por: Sforzini, Luca, et al.
Publicado: (2019)

Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder
por: Leday, Gwenaël G.R., et al.
Publicado: (2018)

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α
por: Baumeister, D, et al.
Publicado: (2016)

Immune targets for therapeutic development in depression: towards precision medicine
por: Drevets, Wayne C., et al.
Publicado: (2022)

Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
por: Chang, Jane Pei-Chen, et al.
Publicado: (2021)

Effects of anti‐inflammatory drugs on the expression of tryptophan‐metabolism genes by human macrophages
por: Regan, Tim, et al.
Publicado: (2018)

The role of circulatory systemic environment in predicting interferon-alpha–induced depression: The neurogenic process as a potential mechanism
por: Borsini, Alessandra, et al.
Publicado: (2019)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
por: Nettis, Maria Antonietta, et al.
Publicado: (2021)

Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
por: Wittenberg, Gayle M., et al.
Publicado: (2019)

Neuroplasticity in mood disorders
por: Drevets, Wayne C.
Publicado: (2004)

T15. LONGITUDINAL ASSOCIATIONS BETWEEN CHILDHOOD SALIVARY CORTISOL LEVELS AND PRODROMAL SYMPTOMS IN LATE ADOLESCENCE: FINDINGS FROM A HIGH-RISK COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
por: Chang, Jane Pei-Chen, et al.
Publicado: (2019)

Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression
por: Hepgul, Nilay, et al.
Publicado: (2016)

The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression
por: Nettis, Maria Antonietta, et al.
Publicado: (2023)

Maternal depression during pregnancy and offspring depression in adulthood: role of child maltreatment
por: Plant, Dominic T., et al.
Publicado: (2015)

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
por: Drevets, Wayne C., et al.
Publicado: (2008)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

Meta-analysis of epigenome-wide association studies of major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
por: Savitz, Jonathan, et al.
Publicado: (2012)

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses
por: Ajnakina, Olesya, et al.
Publicado: (2021)

A word from the ISPNE President
por: Pariante, Carmine M.
Publicado: (2020)

Functional Neuroimaging Correlates of Autobiographical Memory Deficits in Subjects at Risk for Depression
por: Young, Kymberly D., et al.
Publicado: (2015)

Individual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms
por: Misaki, Masaya, et al.
Publicado: (2016)

Identifying the women at risk of antenatal anxiety and depression: A systematic review
por: Biaggi, Alessandra, et al.
Publicado: (2016)

Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?
por: Belvederi Murri, Martino, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kusj2ftu9128ikjc31u039agef